Lipopolysaccharide (LPS) increases susceptibility to epilepsy via interleukin-1 type 1 receptor signaling. Hu A, Yuan H, Qin Y, Zhu Y, et al. Brain Res 2022;1793:148052.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu A, Yuan H, Qin Y, Zhu Y, et al. Lipopolysaccharide (LPS) increases susceptibility to epilepsy via interleukin-1 type 1 receptor signaling. Brain Res 2022;1793:148052.
PMID: 35970265